Trend
DailyDowntrend (starting)
4 hourSymmetric Triangle
1 hourDescending Triangle
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns up above $14.21
Key levels
Resistance$4.80
Resistance$4.13
Support$3.03
Support$2.21
Latest news & SEC filings
NewsLeonaBio Insider Discloses Significant Share Purchase
SEC FilingLeonaBio, Inc. filed an insider trading report (Form 4)
All LONA news →LeonaBio is a drug developer focused on new treatments for difficult cancers and nerve-related diseases. Its two main programs are lasofoxifene, an oral drug taken in a late-stage study for a form of advanced breast tumor driven by a specific gene change, and ATH-1105, an experimental pill for ALS that acts on a growth factor pathway in the brain. The company holds rights to lasofoxifene in most of the world, excluding Asia and some Middle Eastern nations.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
SEPT Low Target
$14.45
SEPT Mid Target
$17.00
SEPT High Target
$19.55
Analyst Consensus
$17.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LONA.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$12.38
7
Moat Score
NONE
2/9
Piotroski Score
-10.7
Altman Z-Score
Insider Signal
SELLING
0 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | director 10% owner | Buy | 776,648 | $776.65 | Oct 26, 2026 |
| Portman David J. | 10% owner | Buy | 3,149,470 | $9.9B | Oct 26, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
1.95%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for LONA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:10:14 | $3.84 | 1,000 | $$4K | SELL |
| 15:36:28 | $3.63 | 1,500 | $$5K | SELL |
| 14:51:37 | $3.92 | 3,500 | $$14K | SELL |
| 16:31:29 | $4.31 | 1,714 | $$7K | SELL |
| 16:11:15 | $4.55 | 7,500 | $$34K | BUY |
5 dark pool trades shown · $$65K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for LONA. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $LONA — PERCEPTIVE ADVISORS LLC | Sale $1K $BOLD — TANG KEVIN | Sale $23K $PDX — Saba Capital Management, L.P. | Sale $256K $PETV — LOWENTHAL GARRY N | Sale $5K $CURB — Lukes David ...
Join 3,500+ traders discussing LONA in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
SEPT's Trading AI has generated a free, downloadable PDF research report for LeonaBio, Inc. (LONA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LeonaBio, Inc. (LONA) is at $3.92, up 1.03% (+$0.04) at the Nov 12, 2026 close.
Latest LONA news — Oct 29, 2026: LeonaBio Insider Discloses Significant Share Purchase · Oct 28, 2026: LeonaBio, Inc. filed an insider trading report (Form 4)
The average analyst price target for LONA is $17.00, ranging from $15 to $20, based on 3 analysts. Latest: Mizuho maintains on Aug 19, 2026.
Analyst ratings for LONA: 2 Buy, 2 Hold, 0 Sell — consensus Hold.
LONA last reported on Aug 14, 2026: EPS -$0.80 vs -$1.39 expected — a beat of 42.4%.
LONA does not currently pay a dividend.
Support: $3.03, $2.21. Resistance: $4.13, $4.80, $5.40.
Insider activity: SELLING, 0 buys and 5 sells in the last 90 days.
Oct 29, 2026: LeonaBio Insider Discloses Significant Share Purchase · Oct 28, 2026: LeonaBio, Inc. filed an insider trading report (Form 4)